| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.086 | 0.5 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |